What is Intertox?
Intertox Inc. operates as a premier U.S.-based scientific consultancy, providing critical toxicological support and risk assessment services. For nearly 25 years, the firm has served as a vital partner for industries requiring rigorous evaluation of chemical and biological agents. By integrating forensic toxicology, litigation support, and comprehensive regulatory guidance, Intertox ensures that its clients maintain the highest standards of public health and environmental safety. Their expertise is instrumental in helping corporations navigate the intersection of scientific innovation and stringent global compliance requirements.
How much funding has Intertox raised?
Intertox has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Intertox
PPP
Public-Private Partnership
What's next for Intertox?
With this recent infusion of capital, Intertox is poised to accelerate its strategic growth initiatives. The firm is expected to leverage these resources to enhance its forensic and regulatory capabilities, potentially expanding its footprint in emerging markets where chemical safety standards are rapidly evolving. By deepening its investment in expert talent and advanced analytical methodologies, Intertox aims to solidify its role as an indispensable advisor for organizations facing increasing scrutiny regarding environmental and biological risks. This late-stage financing provides the necessary runway to scale operations while maintaining the technical precision that has defined the company's reputation for over two decades.
See full Intertox company page
